CD4 and acute myeloid leukemia: study, findings showed higher co-expression of PD-1 and TIGIT in both CD4+ and CD8+ T cells in bone marrow samples of de novo AML patients compared to peripheral blood samples, supporting that there are increased immunosuppressive factors in bone marrow compared to peripheral blood (Table 2) (16).